HIT Consultant May 30, 2024
What You Should Know:
– Virtual Therapeutics, a leader in using engaging games for mental health treatment, announced today it will acquire Akili, Inc. (Nasdaq: AKLI), a prominent digital therapeutics company. This merger creates a diversified powerhouse in the digital health industry.
– Once the acquisition is complete, Akili’s common stock will be delisted from all public stock exchanges. The combined entity’s focus on mental health and broader digital therapeutics solutions positions it to play a major role in improving healthcare outcomes for a wider audience.
Terms of the Agreement
Akili shareholders will receive $0.4340 per share in cash, representing a 4% premium over Akili’s closing price on May 28th, 2024. This translates to a significant 85% increase compared...
Today's Sponsors
Today's Sponsor